Also known as: Sutent Active Ingredient
Sunitinib Malate is the malate salt form of the multi-targeted tyrosine kinase inhibitor Sunitinib, commercially known as Sutent. It demonstrates inhibitory activity against multiple receptor tyrosine kinases including PDGFR-α/β, VEGFR 1/2/3, KIT, FLT3, CSF-1R, and RET. Mediocon Inc supplies GMP-certified Sunitinib Malate API compliant with IP/BP/EP/USP pharmacopoeial standards for global pharmaceutical manufacturers.
| Parameter | Specification |
|---|---|
| CAS Number | 341031-54-7 |
| Molecular Formula | C₂₆H₃₁FN₄O₆ |
| Molecular Weight | 532.55 g/mol |
| Grade | IP / BP / EP / USP |
| Category | Antineoplastic / Tyrosine Kinase Inhibitor |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Mfg Date | MAR 2025 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |